hematology analysis News
-
Optimizing Monoclonal Antibody Production: Temperature And Osmolality’s Impact, Upcoming Webinar Hosted By Xtalks
In this free webinar sponsored by Advanced Instruments, gain insights into advances in monoclonal antibody production technology and manufacturing strategies. Attendees will learn why temperature and osmolality in cell culture are critical parameters affecting cell growth, viability and the concentration of HCPs in the supernatant. The featured speaker will discuss how temperature and osmolality ...
-
Amerigo Scientific Introduces the Launch of Polystreptavidin 350
Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA. Diagnosis is a key enabler of universal health coverage and the first line of defense against the spread of many diseases. From rapid treatment and combating ...
-
First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
Study explores opportunity to shift from clinic to home instillation of this promising non-surgical treatment Potential to transform care and access to treatment for this growing patient population UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat urothelial and specialty cancers, today announced that the ...
-
PixCell Medical and Gamidor Diagnostics Partner to Introduce Point-of-Care Hematology Analysis in Israelq
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced it has signed an exclusive distribution agreement with medical diagnostics company Gamidor Diagnostics to distribute the HemoScreen™, PixCell's hematology analyzer, across Israel. This deal follows a global shift spurred by the COVID-19 pandemic towards near-patient, digitally connected testing ...
-
PixCell Medical Announces Acquisition by Soulbrain Holdings
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired all controlling PixCell shares, as well as investing in the company, making Soulbrain the majority shareholder of PixCell Medical. The acquisition of PixCell aligns with Soulbrain's recent strategic transition into the healthcare and in-vitro diagnostics space. ...
-
PixCell Medical Partners with Axonlab to Distribute Point-of-Care Hematological Analyzer HemoScreen Across Europe
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced an exclusive distribution agreement with Axonlab, a leader in point-of-care testing in Europe providing the healthcare sector with equipment and services in the fields of medical diagnostics, life science, and software solutions, to distribute the HemoScreen™, PixCell's hematology analyzer, in key ...
-
Sysmex Continues to Evolve Its Hematology Product Portfolio
Since its founding in 1968, Sysmex has developed its business by focusing on the hematology field (blood cell count tests), which analyzes the number, type, and size of red and white blood cells as well as platelets. Sysmex has adopted a modular concept since the launch of the XN-Series Automated Hematology Analyzer (“XN-Series”) in 2011, combining modules for blood count, smear ...
-
RURAL Cohort Study to Utilize PixCell Medical`s HemoScreen Hematology Analyzer for Research Initiative
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that the Risk Underlying Rural Areas Longitudinal Study (RURAL) has selected PixCell's novel miniaturized, portable hematology analyzer, HemoScreen™, as part of its six year research study, aiming to gain insight into the specific health-related concerns of the rural southeastern United States' ...
-
Aidian Appointed Sole Distributor of PixCell Medical’s Point-of-Care Hematological Analyzer HemoScreen in the Nordics
PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Aidian, a Finland-based in-vitro diagnostics company providing reliable, fast, and easy-to-use diagnostic tests for primary care. Aidian will serve as the sole distributor of PixCell’s HemoScreen™, a hematology analyzer designed for use at the point of care, with exclusive ...
-
PixCell Medical Partners with Triolab to Distribute Hematological Analyzer HemoScreen in Sweden
PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Triolab, the largest diagnostics distributor in the Nordic and Baltic countries, to be the sole distributor in Sweden of the HemoScreen™, PixCell’s hematology analyzer designed for use at the point of care. “PixCell’s HemoScreen brings lab-quality haematology ...
-
PixCell Medical`s Point-Of-Care Hematology Analyzer Can Play a Key Role in Minimizing Disease Spread
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that The Journal of Applied Laboratory Medicine (JALM) has published a research paper comparing PixCell's HemoScreen™ and its analysis method to standard lab analyzers. Researchers concluded that PixCell's HemoScreen™, a miniature, easy-to-use, AI and machine vision-enabled hematology ...
-
PixCell Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA) for HemoScreen Point-of-Care Hematology Analyzer
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for the HemoScreen™, PixCell's hematology analyzer that offers a 5-part differential CBC intended for point-of-care (POC) use. Under the TGA approval, PixCell's HemoScreen is cleared for use with ...
-
HORIBA Medical welcomes the latest member of the new Yumizen H500 family
As a result of a growing research and development program, HORIBA Medical has recently developed two new products that aim to better meet the needs of today's clinical laboratories : The Yumizen H500 OT ‘Open Tube’ with flexible sampling to accommodate all sample types, particularly for rapid screening in critical care, emergency care and pediatric clinics. The new released ...
-
HORIBA Medical and NOEMALIFE signed a Worldwide Distribution Agreement for a dedicated version of the HALIA middleware
HORIBA Medical is pleased to announce the press release of the worldwide distribution agreement signed between NOEMALIFE (www.noemalife.com/en/) and HORIBA Medical for a dedicated version of the HALIA middleware. The HORIBA Medical middleware is a new product in our IT products range including already our data manager, ABX Pentra ML. This middleware will be the link between all instruments and ...
-
HORIBA acquired 10,000m2 site for new reagent plant in Brazil
Production capacity of hematology reagents is to be doubled Handle expansion in medical services driven by economic growth HORIBA Group's local subsidiary in Brazil, HORIBA ABX Ltda. (1), acquired a 10,000 m2 site(2) on the outskirts of Sao Paolo, Brazil, and will construct a plant there for the manufacture of hematology reagents(3) for hospitals where hematology analyzers are used. The intent ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you